Consistent with tumor suppression, pharmacological inhibition of TGF‐βR1 abrogated Bmal1‐deletion–triggered tumor fibrosis that showed reduced positive structures of FAP, α‐SMA, DESMIN, PDGFRα, and PDGFRβ (Figure 4C–E). This evidence concerns the gene DES and neoplasm.